Closing Panel: The Future of Innate Immune Checkpoints & Activation

Time: 2:30 pm
day: Innate Immune Checkpoints & Activation Pre-Focus Day


  • Delving into the horizons of homing of innate cells and reprograming of the tumor microenvironment
  • Discussing novel checkpoint inhibitors
  • Analysing the various immunotherapy approaches discussed & beyond
  • Updates on clinical trials for immunotherapies
  • In vitro models and discovery technologies for innate cell-based therapies
  • New methodologies of analyzing innate immune cells in the tumor microenvironment (scRNAseq, mass cytometry, highresolution IHC/ISH)